Citadel Securities Starts Windstream (WIN) at Add; Revenue Diversification Leads to a Better L-T Prognosis
Tweet
Share
E-mailGet Alerts WIN Hot Sheet
Price: $0.34 --0%
Rating Summary:
5 Buy, 8 Hold, 9 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 8 Hold, 9 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Citadel Securities initiates coverage on Windstream (NASDAQ: WIN) with a Add. PT $15.
Citadel analyst says, "We rate WIN Add and consider it the best long-term investment of the three RLECs we cover. Windstream’s current valuation appears less favorable than CenturyLink’s, but we think the modest premium is justified; on our 2013 estimates, their valuations largely converge. Beyond that, we believe Windstream has better prospects for sustained revenue and EBITDA growth. Thus, while CenturyLink may offer more near-term upside, we think patient investors will be better rewarded with a long position in Windstream."
For more ratings news on Windstream click here and for the rating history of Windstream click here.
Shares of Windstream closed at $12.68 yesterday.
Citadel analyst says, "We rate WIN Add and consider it the best long-term investment of the three RLECs we cover. Windstream’s current valuation appears less favorable than CenturyLink’s, but we think the modest premium is justified; on our 2013 estimates, their valuations largely converge. Beyond that, we believe Windstream has better prospects for sustained revenue and EBITDA growth. Thus, while CenturyLink may offer more near-term upside, we think patient investors will be better rewarded with a long position in Windstream."
For more ratings news on Windstream click here and for the rating history of Windstream click here.
Shares of Windstream closed at $12.68 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- Oppenheimer Starts Carriage Services (CSV) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
